Compare SHASUN PHARMA with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs TTK HEALTHCARE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA TTK HEALTHCARE SHASUN PHARMA/
TTK HEALTHCARE
 
P/E (TTM) x 123.9 18.7 661.5% View Chart
P/BV x 8.5 1.5 568.9% View Chart
Dividend Yield % 0.2 1.0 22.6%  

Financials

 SHASUN PHARMA   TTK HEALTHCARE
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
TTK HEALTHCARE
Mar-19
SHASUN PHARMA/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs941,215 7.8%   
Low Rs46610 7.5%   
Sales per share (Unadj.) Rs214.2444.4 48.2%  
Earnings per share (Unadj.) Rs5.317.2 30.9%  
Cash flow per share (Unadj.) Rs15.827.6 57.3%  
Dividends per share (Unadj.) Rs1.005.00 20.0%  
Dividend yield (eoy) %1.40.5 261.1%  
Book value per share (Unadj.) Rs53.3177.9 30.0%  
Shares outstanding (eoy) m56.6214.13 400.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.32.1 15.9%   
Avg P/E ratio x13.152.9 24.8%  
P/CF ratio (eoy) x4.433.0 13.4%  
Price / Book Value ratio x1.35.1 25.6%  
Dividend payout %18.729.0 64.6%   
Avg Mkt Cap Rs m3,95812,894 30.7%   
No. of employees `000NA2.3 0.0%   
Total wages/salary Rs m2,1641,307 165.5%   
Avg. sales/employee Rs ThNM2,715.7-  
Avg. wages/employee Rs ThNM565.3-  
Avg. net profit/employee Rs ThNM105.4-  
INCOME DATA
Net Sales Rs m12,1276,279 193.1%  
Other income Rs m22978 295.9%   
Total revenues Rs m12,3566,356 194.4%   
Gross profit Rs m1,009496 203.6%  
Depreciation Rs m594147 404.6%   
Interest Rs m41534 1,228.1%   
Profit before tax Rs m230393 58.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-73149 -48.8%   
Profit after tax Rs m302244 124.0%  
Gross profit margin %8.37.9 105.4%  
Effective tax rate %-31.737.9 -83.5%   
Net profit margin %2.53.9 64.2%  
BALANCE SHEET DATA
Current assets Rs m6,8842,717 253.4%   
Current liabilities Rs m8,4561,571 538.3%   
Net working cap to sales %-13.018.3 -71.0%  
Current ratio x0.81.7 47.1%  
Inventory Days Days6232 191.7%  
Debtors Days Days10847 230.5%  
Net fixed assets Rs m4,970991 501.5%   
Share capital Rs m113141 80.2%   
"Free" reserves Rs m2,8752,373 121.2%   
Net worth Rs m3,0202,514 120.1%   
Long term debt Rs m1,8173 53,452.9%   
Total assets Rs m13,3474,158 321.0%  
Interest coverage x1.612.6 12.3%   
Debt to equity ratio x0.60 44,499.3%  
Sales to assets ratio x0.91.5 60.2%   
Return on assets %5.46.7 80.5%  
Return on equity %10.09.7 103.2%  
Return on capital %13.316.9 78.7%  
Exports to sales %46.43.6 1,292.4%   
Imports to sales %14.20.5 2,890.3%   
Exports (fob) Rs m5,622225 2,496.2%   
Imports (cif) Rs m1,72831 5,582.2%   
Fx inflow Rs m5,843225 2,594.4%   
Fx outflow Rs m2,17371 3,056.0%   
Net fx Rs m3,669154 2,381.4%   
CASH FLOW
From Operations Rs m398173 229.7%  
From Investments Rs m-1,63597 -1,694.3%  
From Financial Activity Rs m1,309-307 -425.8%  
Net Cashflow Rs m71-38 -188.9%  

Share Holding

Indian Promoters % 39.2 65.4 59.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 3.7 97.3%  
FIIs % 17.6 5.2 338.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 25.8 153.5%  
Shareholders   20,750 12,723 163.1%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   SUN PHARMA  DR. REDDYS LAB  GSK PHARMA  FULFORD INDIA  PROCTER & GAMBLE HEALTH  

Compare SHASUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 172 Points Higher; IT and Power Stocks Witness Buying(Closing)

Indian share markets continued to trade on a positive note during closing hours and ended their session near day's high.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

A Simple, 7-Step Checklist for Your Trading Success

Dec 4, 2019

What we can learn from one of the greatest traders to have ever lived.

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

Growth Stocks or Value Stocks... What Will Make You More Money in this Bull Market?(Profit Hunter)

Nov 28, 2019

Should you invest in growth stocks or value stocks to make strong returns in this market?

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020(Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

What Is the IPO Euphoria Signaling Us About the Markets?(The 5 Minute Wrapup)

Dec 2, 2019

2019 will be remembered as the year of great money-making IPOs...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA - TORRENT PHARMA COMPARISON

COMPARE SHASUN PHARMA WITH

MARKET STATS